Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1266
-
Total 13F shares, excl. options
-
1.38B
-
Shares change
-
-25M
-
Total reported value, excl. options
-
$114B
-
Value change
-
-$1.97B
-
Put/Call ratio
-
1.24
-
Number of buys
-
670
-
Number of sells
-
-535
-
Price
-
$82.91
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2014
1,412 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2014.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,266 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.38B shares
.
Largest 10 shareholders include Capital Research Global Investors (138M shares), FMR LLC (98.8M shares), VANGUARD GROUP INC (78.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (67M shares), State Street Corp (61.5M shares), BlackRock Institutional Trust Company, N.A. (40.1M shares), Capital World Investors (38.6M shares), Invesco Ltd. (28.6M shares), GOLDMAN SACHS GROUP INC (28.3M shares), and WELLINGTON MANAGEMENT CO LLP (22.4M shares).
This table shows the top 1266 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.